| FORM 990, PART I, LINE 1, ORGANIZATION'S MISSION: |
ADMINISTER GIFTS AND GRANTS IN KEEPING WITH THE HEALTH RESEARCH, PREVENTION AND TREATMENT PURPOSE OF THE NYS DEPARTMENT OF HEALTH, THE ROSWELL PARK CANCER INSTITUTE CORPORATION AND OTHER HEALTH RELATED PUBLIC AND PRIVATE ENTITIES; ALSO INCLUDING INTELLECTUAL PROPERTY MANAGEMENT AND TECHNOLOGY TRANSFER. |
| FORM 990, PART III, LINE 1, SIGNIFICANT ACTIVITIES: |
THE FOLLOWING AWARDS HIGHLIGHT A FEW OF THE MANY SPONSORED PROJECTS THAT HEALTH RESEARCH, INC HAS RECEIVED FUNDING FOR DURING THE REPORTING PERIOD: PATHWAYS TO SUCCESS NEW YORK STATE BUILDING SUPPORTIVE COMMUNITIES FOR YOUNG FAMILIES IN NEW YORK CITY OFFICE OF THE ASSISTANT SECRETARY OF HEALTH THIS PROJECT WILL IMPLEMENT THE PATHWAYS TO SUCCESS INITIATIVE IN NEW YORK CITY, PARTNERING WITH THE LIVING FOR THE YOUNG FAMILY THROUGH EDUCATION PROGRAM, INSTITUTES OF HIGHER EDUCATION AND PUBLIC HEALTH SOLUTIONS. THE PROJECT WILL UTILIZE EVIDENCE-INFORMED APPROACHES TO PROVIDE LINKAGES TO REPRODUCTIVE HEALTH CARE, PRIMARY HEALTH CARE, WELL CHILD VISITS, NUTRITIONAL COUNSELING AND SERVICES, EARLY CHILDHOOD EDUCATION, ACADEMIC SUPPORTS, LIFE SKILLS, COLLEGE PLANNING AND READINESS, SAFE AND STABLE HOUSING, TRANSPORTATION SUPPORT, PARENTING EDUCATION AND RESOURCES, AND HEALTH RELATIONSHIP EDUCATION, AND CREATE A SEAMLESS NETWORK OF SERVICES FOR EXPECTANT AND PARENTING STUDENTS TO ASSESS THEIR NEEDS AND ASSETS. ALTERNATIVE RIBOSOMES AND ANTIBIOTIC TOLERANCE IN MYCOBACTERIA NATIONAL INSTITUTES OF HEALTH (NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES) BY INVESTIGATING THE ROLE OF ALTERNATIVE RIBOSOMES IN TOLERANCE OF MYCOBACTERIA TO RIBOSOMAL ANTIBIOTICS, THIS PROJECT WILL OPEN UP NEW POSSIBILITIES OF EFFICIENTLY TARGETING MYCOBACTERIAL RIBOSOMES AND THUS CONTROL DRUG RESISTANT TUBERCULOSIS. NEW YORK STATE OPIOID STATE TARGETED RESPONSE PROJECT THE RESEARCH FOUNDATION FOR MENTAL HYGIENE THIS PROGRAM AIMS TO ADDRESS THE OPIOID CRISIS BY INCREASING ACCESS TO TREATMENT, REDUCING UNMET TREATMENT NEED, AND REDUCING OPIOID OVERDOSE RELATED DEATHS THROUGH THE PROVISION OF PREVENTION, TREATMENT AND RECOVERY ACTIVITIES FOR OPIOID USE DISORDER. HIGH THROUGHPUT SCREENING OF ORTHOSTERIC INHIBITORS OF FLAVIVIRUS PROTEASE NATIONAL INSTITUTES OF HEALTH (NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES) MANY FLAVIVIRUSES SUCH AS DENGUE VIRUS, ZIKA VIRUS, WEST NILE VIRUS, AND YELLOW FEVER VIRUS CAUSE SIGNIFICANT HUMAN DISEASES. HOWEVER, NO CLINICALLY APPROVED ANTIVIRAL THERAPY IS AVAILABLE FOR TREATMENT OF FLAVIVIRUS INFECTIONS. THE LONG TERM GOAL OF THIS PROJECT IS TO ADDRESS THE NEED FOR DEVELOPING A NEW SYSTEM TO IDENTIFY, SCREEN AND VALIDATE A CLASS OF POTENTIAL FLAVIVIRUS INHIBITORS, AND SUCCESSFULLY IDENTIFY AND ANALYZE CANDIDATE COMPOUNDS THAT SHOW PROMISE IN DISRUPTING VIRAL SURVIVAL. |
| FORM 990, PART III, LINE 4A, FEDERALLY FUNDED HIV AIDS PREVENTION AND CARE |
PROGRAMS: THE HIV UNINSURED CARE PROGRAMS PROVIDE MEDICATIONS AND MEDICAL CARE TO UNINSURED AND UNDERINSURED NEW YORK STATE RESIDENTS LIVING WITH OR AT RISK OF ACQUIRING HIV/AIDS. THE PROGRAMS ARE MANAGED BY THE NEW YORK STATE DEPARTMENT OF HEALTH, AIDS INSTITUTE. HEALTH RESEARCH, INC. (HRI) SERVES AS THE FISCAL ADMINISTRATOR FOR THE PROGRAMS. THE AIDS DRUG ASSISTANCE PROGRAM (ADAP) BEGAN IN 1987 AS PART OF A NATIONAL PROGRAM TO PROVIDE FREE HIV/AIDS DRUGS TO LOW-INCOME INDIVIDUALS NOT COVERED BY MEDICAID OR ADEQUATE THIRD-PARTY INSURANCE. NEW YORK STATE EXPANDED THE PROGRAM TO INCLUDE AMBULATORY CARE AND HOME CARE SERVICES, INSURANCE CONTINUATION AND PRE-EXPOSURE PROPHYLAXIS. THE PROGRAMS ARE FUNDED THROUGH PARTNERSHIPS BETWEEN THE STATE AND FEDERAL GOVERNMENTS AND BETWEEN THE STATE AND THE NEW YORK CITY, LONG ISLAND AND LOWER HUDSON RYAN WHITE PART A REGIONS. BOTH FEDERAL AND STATE STATUTE/REGULATION GOVERNS THE PROGRAMS. THE FEDERAL RYAN WHITE HIV/AIDS TREATMENT EXTENSION ACT OF 2009 INCLUDES STATUTORY AUTHORITY FOR AIDS DRUG ASSISTANCE PROGRAMS THROUGHOUT THE NATION, AND ASSOCIATED APPROPRIATIONS PROVIDE FEDERAL FUNDING TO SUPPORT THE PROGRAMS. IN ADDITION, STATE REGULATION IN NYCRR, TITLE 10, SUB-PART 43-2 GOVERNS THE APPLICATION AND ELIGIBILITY DETERMINATION PROCESS AND ESTABLISHES THE RIGHTS AND RESPONSIBILITIES OF APPLICANTS, PARTICIPANTS, AND PROVIDERS. NEW YORK STATE'S HIV UNINSURED CARE PROGRAMS ARE THE MOST COMPREHENSIVE IN THE NATION, OFFERING A FULL SCOPE OF SERVICES TO PERSONS WITH HIV/AIDS. MORE THAN 120,000 INDIVIDUALS HAVE RECEIVED SERVICES SINCE THE PROGRAM STARTED, AND MORE THAN 24,000 UNIQUE INDIVIDUALS WERE SERVED IN 2017-18. |
| FORM 990, PART III, LINE 4B, CANCER RESEARCH: |
HEALTH RESEARCH, INC. WAS ESTABLISHED IN 1953 TO AID ROSWELL PARK CANCER INSTITUTE (RPCI) IN ATTRACTING AND MANAGING DONATIONS AND GRANTS TO FURTHER ITS CANCER RESEARCH. THE MISSION OF RPCI IS TO UNDERSTAND, PREVENT AND CURE CANCER. RPCI, FOUNDED IN 1898, WAS ONE OF THE FIRST CANCER CENTERS IN THE COUNTRY TO BE NAMED BY THE NATIONAL INSTITUTE OF HEALTH (NIH) AS A NATIONAL CANCER INSTITUTE-DESIGNATED COMPREHENSIVE CANCER CENTER AND REMAINS THE ONLY FACILITY WITH THIS DESIGNATION IN UPSTATE NEW YORK. ROSWELL PARK CANCER INSTITUTE IS A MULTIDISCIPLINARY, TRANSLATIONAL COMPREHENSIVE CANCER CENTER, WITH A MISSION TO ELIMINATE CANCER'S GRIP ON HUMANITY BY UNLOCKING ITS SECRETS THROUGH PERSONALIZED APPROACHES AND UNLEASHING THE HEALING POWER OF HOPE. RPCI UTILIZES ITS COMPREHENSIVE CANCER SUPPORT GRANT (CCSG) TO BUILD ON UNIQUE STRENGTHS AND OPPORTUNITIES, MOVING LABORATORY SCIENCE INTO ADVANCED TREATMENT, PREVENTION, DIAGNOSIS, AND EDUCATION. ROSWELL PARK CANCER INSTITUTE'S REVOLUTIONARY RESEARCH MODEL OF A "MULTIDISCIPLINARY APPROACH" TO CANCER - WITH SCIENTISTS AND CLINICIANS WORKING IN CONCERT AND IN CONSULT - HAS BECOME THE STANDARD BY WHICH ALL MODERN-DAY COMPREHENSIVE CANCER CENTERS ARE MEASURED. DR. CANDACE JOHNSON CONTINUES IN HER LEADERSHIP ROLE AT RPCI, WHICH SHE TOOK IN NOVEMBER 2014. DR. JOHNSON HAS EXTENSIVE ACADEMIC, ADMINISTRATIVE, AND SCIENTIFIC EXPERTISE. DR. KUNLE ODUNSI WAS APPOINTED AS DEPUTY DIRECTOR IN APRIL 2015. HE CONTINUES HIS LEADERSHIP OF THE TUMOR IMMUNOLOGY AND IMMUNOTHERAPY PROGRAM. DR. ODUNSI ALSO SERVES AS EXECUTIVE DIRECTOR OF THE CENTER FOR IMMUNOTHERAPY. BOTH ARE EXPERIENCED AND WORLD RENOWNED RESEARCHERS. HRI CONTINUES TO WORK WITH RPCI LEADERSHIP IN ALL OF THEIR RESEARCH ENDEAVORS. HRI'S CANCER RESEARCH GRANT PORTFOLIO SUPPORTS A NATIONALLY RECOGNIZED RESEARCH ENTERPRISE AT RPCI. THE BUFFALO COMPREHENSIVE CANCER CENTER IS NATIONALLY RANKED AND IS ONE OF ONLY 45 COMPREHENSIVE CANCER CENTERS IN THE COUNTRY. HEALTH RESEARCH INCORPORATED (HRI) PROVIDES EFFECTIVE PRE- AND POST-AWARD EVALUATION, SOLICITATION, AND ADMINISTRATION OF EXTERNAL RESEARCH SUPPORT FROM FEDERAL AND STATE AGENCIES, NOT FOR-PROFIT FOUNDATIONS AND COMMERCIAL FIRMS IN ACCORDANCE WITH THE REQUIREMENTS OF THE SPONSOR. THE HRI/GRANTS MANAGEMENT STAFF (22 FTES) SUPPORT MORE THAN 573 ACTIVE GRANTS ANNUALLY FOR RPCI, PROVIDING TIMELY AND DETAILED GRANT REVENUE AND EXPENDITURE INFORMATION FOR INTERNAL AND EXTERNAL REVIEW, AS WELL AS ANALYSIS WITH INSTITUTE INVESTIGATORS. HRI'S SUPERIOR GRANT ADMINISTRATION EXPERTISE AND ITS ABILITY TO ATTRACT HIGHLY QUALIFIED RESEARCH STAFF HAVE CONTRIBUTED TO THE CONTINUED UPWARD TRAJECTORY OF THE INSTITUTION AND IT'S CANCER RESEARCH. HRI-ROSWELL PARK DIVISION CURRENTLY HAS 573 ACTIVE PROJECTS TOTALING $86 MILLION, OF WHICH $53.2 MILLION ARE PEER REVIEWED AWARDS. HRI-ROSWELL PARK'S LARGEST SPONSOR IS THE NATIONAL INSTITUTE OF HEALTH (NIH) REPRESENTING 2/3 OF TOTAL FUNDING. HRI-ROSWELL PARK DIVISION RECEIVED MORE THAN $103.4 MILLION OF REVENUE IN FY18. |
| FORM 990, PART III, LINE 4C, PUBLIC HEALTH AND HEALTH CARE EMERGENCY |
PREPAREDNESS: HEALTH RESEARCH, INC. (HRI) GRANT FUNDS (CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) PUBLIC HEALTH EMERGENCY PREPAREDNESS (PHEP) AND THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR) HOSPITAL PREPAREDNESS PROGRAM (HPP) COOPERATIVE AGREEMENT (CA) FUNDS SUPPORT THE EFFORTS OF THE NEW YORK STATE DEPARTMENT OF HEALTH (NYSDOH) OFFICE OF HEALTH EMERGENCY PREPAREDNESS (OHEP). OHEP CONTINUES TO WORK WITH THE STATE OFFICE OF EMERGENCY MANAGEMENT (STATE OEM) AND OTHER STATE AGENCIES, LOCAL HEALTH DEPARTMENTS (LHD) AND PRIVATE AND PUBLIC-SECTOR PARTNERS TO BUILD A SOLID EMERGENCY PREPAREDNESS AND RESPONSE FOUNDATION TO RESPOND TO ANY CRISIS OR EMERGENT SITUATION IN THE STATE. BASED ON AN ASSESSMENT OF NYSDOH CAPABILITIES AND GAPS AND CONSIDERING REDUCED PHEP AND HPP FUNDING, NYSDOH HAS CAREFULLY REVIEWED ITS PROGRESS IN DESIGNING AN INTEGRATED AND COMPREHENSIVE HEALTH EMERGENCY PREPAREDNESS STRUCTURE AND HAS STRATEGICALLY PRIORITIZED FUTURE EFFORTS. A STRATEGIC PLAN WAS DEVELOPED TO PRIORITIZE THE CDC PUBLIC HEALTH PREPAREDNESS AND ASPR HEALTHCARE PREPAREDNESS AND JOINT CAPABILITIES. THE STRATEGIC PLAN DIRECTS FUNDING TO CAPABILITIES THAT ENABLE EMERGENCY PLANNING AND RESPONSE EFFORTS TO BE ENHANCED OR SUSTAINED, WITH A FOCUS ON THOSE AREAS THAT ARE MOST CRITICAL FOR THE NYSDOH'S HEALTH EMERGENCY PREPAREDNESS EFFORTS. * NYSDOH OHEP CONTINUES TO SUSTAIN ITS FULLY DEVELOPED INCIDENT MANAGEMENT SYSTEM (IMS). ACCOMPLISHMENTS FROM THE PERIOD 04/01/2017 TO 03/31/2018 * 100% OF SUBJECT MATTER EXPERTS (SME) THROUGHOUT NYSDOH WERE TRAINED ON ROLES AND RESPONSIBILITIES DURING AN EMERGENCY THROUGH EXISTING BI-WEEKLY SUBJECT MATTER LEAD (SML) MEETINGS. * NYSDOH'S IMS WAS ACTIVATED FOR SEVENTEEN (17) INCIDENTS ORGANIZING COMMAND AND OPERATIONAL STRUCTURES AT STATE AND/OR REGIONAL LEVEL. * DURING 2017-2018, IMS DASHBOARD DEVELOPMENT CONTINUED WITH PROGRESS CHECKPOINTS ON TRACK FOR IMPLEMENTATION. * VIRTUAL HEALTH OPERATION CENTER (VHOC) 2.0 DEVELOPMENT CONTINUED WITH PROGRESS CHECKPOINTS ON TRACK FOR IMPLEMENTATION AND TRAINING OF NEW FEATURES. 2. NYSDOH OHEP CONTINUES TO SUPPORT AND PROVIDE UPDATED GUIDANCE FOR DISTRIBUTION AND DISPENSING OF MEDICAL COUNTERMEASURES (MCM), INCLUDING VACCINES AND MEDICATIONS, USING LOCAL POINTS OF DISPENSING (POD)/CLINIC OPERATIONS. NYSDOH OHEP HAS FOCUSED ON RESEARCHING ALTERNATE DISPENSING STRATEGIES SUCH AS CLOSED POD PARTNERSHIPS, THAT MAY INCLUDE PRIMARY CARE PROVIDERS, HEALTHCARE FACILITIES, PHARMACIES AND PRIVATE BUSINESS LOCATIONS. DURING 2017-2018, NYSDOH OHEP WORKED WITH LOCAL JURISDICTIONS TO IMPROVE THEIR ABILITIES TO RESPOND TO AN EVENT REQUIRING DISTRIBUTION AND DISPENSING OF MCM TO THEIR POPULATION FOR PROPHYLAXIS, TREATMENT OR OTHER MEASURES TO PROTECT THE PUBLIC HEALTH AND SAFETY. ACCOMPLISHMENTS FROM THE PERIOD 04/01/2017 TO 03/31/2018 * ALL FIFTY-SEVEN (57) LHDS AND ONE HUNDRED THIRTY-NINE (139) HOSPITALS ATTENDED MCM TRAINING. * NYSDOH OHEP PROVIDED TRAINING ON THE CDC MCM OPERATIONAL READINESS REVIEW (ORR) TOOL TO ALL FOURTEEN (14) CITIES READINESS INITIATIVE (CRI) JURISDICTIONS. * NYSDOH OHEP WORKED WITH THE UNKECHAUG, ST. REGIS MOHAWK AND THE SENECA NATION OF INDIANS TRIBAL NATIONS IN THE AREAS OF PLANNING FOR PODS, RADIOLOGICAL EMERGENCIES, MASS FATALITY INCIDENTS AND COMMUNITY PREPAREDNESS. * NYSDOH PARTICIPATED IN AN INTEGRATED INCIDENT RESPONSE WITH THE FRANKLIN LHD AND THE ST. REGIS MOHAWK TRIBAL NATION IN A POD TO DISTRIBUTE THE MCM TETANUS, DIPHTHERIA, PERTUSSIS (TDAP) IN RESPONSE TO LOCAL FLOODING. 3. NYSDOH CONTINUES TO SUPPORT THE MEDICAL EMERGENCY RESPONSE INVENTORY SYSTEM (MERITS). MERITS IS AN ELECTRONIC INVENTORY MANAGEMENT SYSTEM THAT SUPPORTS THE STRATEGIC NATIONAL STOCKPILE (SNS) AND THE STATE'S MEDICAL EMERGENCY RESPONSE CACHE (MERC) WAREHOUSE OPERATIONS. THIS INCLUDES PROCESSING ORDERS, RECEIVING, SHIPPING, REPORTING AND MAINTAINING A MASTER INVENTORY OF ALL ASSETS. NYSDOH OHEP CONTINUES TO SUSTAIN MEDICAL MATERIEL MANAGEMENT AND DISTRIBUTION CAPACITY TO RESPOND TO A PUBLIC HEALTH THREAT WITH MEDICAL COUNTERMEASURES AND/OR DURABLE MEDICAL EQUIPMENT TO PROVIDE FOR A TIMELY AND EFFECTIVE RESPONSE. ACCOMPLISHMENTS FROM THE PERIOD 04/01/2017 TO 03/31/2018 * NYSDOH OHEP ATTENDED BI-WEEKLY MEETINGS WITH INFORMATION TECHNOLOGY STAFF TO ASSESS SYSTEM PERFORMANCE AND DISCUSS ENHANCEMENTS TO MERITS. * TWO REFRIGERATED TRAILERS AND MASS FATALITY TEMPORARY STORAGE EQUIPMENT AND SUPPLIES INCLUDING 1,100 HUMAN REMAINS POUCHES, EBOLA VIRUS DISEASE (EVD) REMAINS DISPOSITION PACKAGING SYSTEMS, NITRILE GLOVES, IMPERMEABLE N-95 DISPOSABLE RESPIRATORS, APRONS AND HOODS WERE MAINTAINED AND ARE READY FOR DEPLOYMENT. * MERC INVENTORY OF THE RADIOLOGICAL MEDICAL INTERVENTIONS PRUSSIAN BLUE AND ANTI-NEUTROPENIC WAS REPLENISHED. * 100% OF ALL EXPIRED SUPPLIES WERE REPLENISHED IN THE FEDERAL MEDICAL STATION (FMS). * LOGISTICS STAFF CONTINUED TO PROVIDE SUPPORT TO THE FEDERAL CHEMPACK PROGRAM BY ACCOMPANYING CDC WITH SUSTAINMENT EFFORTS AT SEVENTY-TWO STATEWIDE LOCATIONS. IN OCTOBER 2017, ALL STATEWIDE CHEMPACK CONTAINERS WERE VISITED TO EXCHANGE EXPIRED PRODUCT. 4. NYSDOH CONTINUES TO SUPPORT INFORMATICS INFRASTRUCTURE TO PROVIDE ELECTRONIC, SECURE SYSTEMS AND APPLICATIONS FOR EMERGENCY PREPAREDNESS, RESPONSE AND RECOVERY. NYSDOH WILL SUSTAIN AND IMPROVE SYSTEMS FOR INFORMATION EXCHANGE. IN-PLACE ARCHITECTURE WAS LEVERAGED AND NEW COMPONENTS WERE ADDED THAT LINK NYSDOH WITH ITS EMERGENCY PREPAREDNESS AND RESPONSE PARTNERS AND PROMOTED THE EXCHANGE OF DATA WITH STAKEHOLDERS, BI-DIRECTIONALLY, WHILE ENSURING APPROPRIATE PRIVACY PROTECTION. ACCOMPLISHMENTS FROM THE PERIOD 04/01/2017 TO 03/31/2018 * NYSDOH PROVIDED USER TRAINING AND TECHNICAL ASSISTANCE (TA) TO ALL FIFTY-SEVEN (57) LHDS ON THE UPDATED SERVNY 2.0 VOLUNTEER MANAGEMENT SYSTEM. * NYSDOH'S COMMUNICABLE DISEASE ELECTRONIC SURVEILLANCE SYSTEM (CDESS) CAN SUBMIT HL7 MESSAGES TO CDC. GENV2, ARBOVIRAL AND HEPATITIS MESSAGE MAPPING GUIDE STANDARDS HAVE BEEN IMPLEMENTED AND APPLICABLE CASES ARE REPORTED VIA HL7. * A NEW TEXT SEARCHING FILTER WAS DEVELOPED TO IDENTIFY OPIOIDS OVERDOSE PATIENTS FROM EMERGENCY DEPARTMENT (ED) VISIT DATA AND ASSIST IN ADDRESSING THE DRUG OVERDOSE EPIDEMIC. OPIOIDS OVERDOSE SYNDROME WAS ADDED TO THE ELECTRONIC SYNDROMIC SURVEILLANCE SYSTEM (ESSS) TO PROVIDE DAILY SURVEILLANCE OF OPIOIDS OVERDOSE IN NYS. * NYSDOH DEVELOPED AND IMPLEMENTED A NEW SYSTEM USING BACKEND FUNCTIONALITY OF INTEGRATED HEALTH ALERTING NETWORK SYSTEM (IHANS) TO PROVIDE ABILITY TO CALL MEMBERS OF THE PUBLIC AFFECTED BY EMERGENT OR EMERGENCY EVENTS BY WAY OF PHONE CALL WITH TEXT TO SPEECH OR AUDIO FILE. * NYSDOH CRISIS AND EMERGENCY RISK COMMUNICATION (CERC) INFORMATION SHARING WORKGROUP IS EXPANDED TO SIXTY-FIVE REGULAR ATTENDEES INCLUDING LHD PUBLIC INFORMATION OFFICERS (PIO). THIRTY-THREE, 58% OF THE LHDS PARTICIPATED IN THE MOST RECENT CERC INFORMATION SHARING WORKGROUP WEBINAR. 5. NYSDOH CONTINUES TO SUSTAIN AND BUILD PUBLIC HEALTH LABORATORY TESTING CAPABILITY OF THE NYSDOH WADSWORTH CENTER (WC), TO INCLUDE TESTING OF CLINICAL, ENVIRONMENTAL, FOOD AND WATER SAMPLES. LABORATORY TESTING CONTINUES TO BE A PRIORITY AREA INCLUDING COORDINATION AND COMMUNICATION EFFORTS AND BUILDING ADDITIONAL CAPABILITIES. THIS INCLUDES: LABORATORY RESPONSE NETWORK (LRN)-BIOTERRORISM (B) GOALS INCLUDE RAPID TESTING USING LRN PROTOCOLS AND REPORTING TO SUBMITTERS TO PROVIDE INFORMATION FOR PROMPT DECISION MAKING. LRN-B WILL SUSTAIN THE ABILITY FOR CONTACTING THE SENTINEL LABORATORIES IN NYS THROUGH THE HEALTH COMMERCE SYSTEM (HCS). LRN-CHEMICAL (C) GOALS INCLUDE THE ADOPTION OF TECHNOLOGY TO PROCESS AND MAINTAIN THE POSITIVE IDENTIFICATION OF THE LARGE NUMBER OF SPECIMENS THAT ARE HANDLED DURING SURGE TESTING AND TO USE THE REFERENCE MATERIALS THAT ARE NOW SUPPLIED BY THE CDC FOR METHOD IMPROVEMENT AND THE FULL VALIDATION OF ANALYTICAL PROTOCOLS. ACCOMPLISHMENTS FROM THE PERIOD 04/01/2017 TO 03/31/2018 * LRN-B PROVIDED RAPID RESPONSE TESTING SERVICES FOR CLINICAL AND ENVIRONMENTAL SAMPLES. * LRN-C HAS HAD ERRORS IN GAS CHROMATOGRAPHY-MASS SPECTROMETRY (GC/MS) ANALYSIS SO TRIALS TO ASSESS PERFORMANCE CHARACTERISTICS AND RUGGEDNESS OF SEVERAL TESTING PLATFORMS WILL BE EVALUATED IN ANTICIPATION OF A REPLACEMENT LABORATORY EQUIPMENT PURCHASE. 6. THE NYSDOH CONTINUES TO SUSTAIN AND ENHANCE ITS COMMUNICABLE DISEASE SURVEILLANCE SYSTEMS THAT COLLECT INFORMATION FROM MULTIPLE DATA STREAMS DAILY TO ENSURE A BASELINE OF EPIDEMIOLOGIC DATA FOR NYS. NYSDOH CONTINUES TO SUSTAIN THE CAPABILITY TO ANALYZE AND INTERPRET EPIDEMIOLOGIC DATA THAT IS CRITICAL TO THE PRACTICE OF PUBLIC HEALTH. |
| FORM 990, PART III, LINE 4C |
ACCOMPLISHMENTS FROM THE PERIOD 04/01/2017 TO 03/31/2018 * BETWEEN AUGUST 1, 2017 AND JANUARY 31, 2018 APPROXIMATELY 99% OF CATEGORY I INVESTIGATIONS WERE INITIATED IN AN APPROPRIATE TIME FRAME; APPROXIMATELY 94% OF CATEGORY II INVESTIGATIONS WERE INITIATED IN AN APPROPRIATE TIME FRAME; APPROXIMATELY 99% OF CATEGORY III INVESTIGATIONS WERE INITIATED IN AN APPROPRIATE TIME FRAME; APPROXIMATELY 99% OF CATEGORY A DISEASE CASE REPORTS WERE COMPLETED; APPROXIMATELY 95% OF CATEGORY B DISEASE CASE REPORTS WERE COMPLETED; AND APPROXIMATELY 99% OF CATEGORY C DISEASE CASE REPORTS WERE COMPLETED. * NYSDOH EPIDEMIOLOGICAL STAFF PARTICIPATED IN ALL SCHEDULED NATIONAL NOTIFIABLE DISEASE SURVEILLANCE SYSTEM (NNDSS) MODERNIZATION INITIATIVE CONFERENCE CALLS, COMPLETED THE GAP ANALYSIS AND TECHNICAL WORK FOR GENERAL DISEASE, ARBOVIRAL DISEASE AND HEPATITIS DISEASE NOTIFICATIONS. STAFF ARE CURRENTLY WORKING ON THE GAP ANALYSIS FOR THE FOODBORNE AND DIARRHEAL DISEASES MESSAGE MAPPING GUIDE. PROGRAM PERIOD SUCCESSES: DISASTER MENTAL HEALTH (DMH) ON FEBRUARY 9, 2018, A DISASTER MENTAL HEALTH (DMH) TRAINING ENTITLED "MENTAL HEALTH CONSEQUENCES OF MASS VIOLENCE" WAS SIMULTANEOUSLY WEBCAST TO MORE THAN TWENTY SITES THROUGHOUT NYS. APPROXIMATELY 350 INDIVIDUALS ATTENDED THE TRAINING. THE WEBCAST WAS RECORDED AND ARCHIVED ON THE NYS LEARNING MANAGEMENT SYSTEM (LMS). COALITION SURGE TEST (CST) 2018 NYSDOH OHEP CONDUCTED A SERIES OF SEVEN (7), NINETY (90) MINUTE REGIONAL FUNCTIONAL AND FACILITATED DISCUSSION EXERCISES BETWEEN JANUARY 23 AND FEBRUARY 21, 2018. THE EXERCISES FOCUSED ON THE EVACUATION OF THREE LARGE HOSPITALS IN EACH REGION, TOTALING TWENTY PERCENT OF THE REGION'S ACUTE CARE BED CAPACITY. THE GOAL WAS TO FIND AS MANY CLINICALLY APPROPRIATE, STAFFED ACUTE-CARE BEDS AS POSSIBLE WITHIN NINETY MINUTES, AS WELL AS TRANSPORTATION ASSETS MATCHED TO THE ACUITY LEVEL OF EACH PATIENT. DATA WAS COLLECTED USING FEDERAL-DEVELOPED FORMS WHICH ALIGNED WITH HOSPITAL PREPAREDNESS PROGRAM (HPP) PERFORMANCE MEASURES. THE EXERCISE WAS FUNCTIONAL AND NO ACTUAL PATIENT MOVEMENT OCCURRED. THE EXERCISE TESTED SEVERAL CAPABILITIES: FOUNDATION FOR HEALTH CARE AND MEDICAL READINESS (EMERGENCY MANAGEMENT COORDINATION); HEALTH CARE AND MEDICAL RESPONSE COORDINATION (INFORMATION SHARING); AND MEDICAL SURGE. HEALTH CARE COALITION LEADS COLLECTED INFORMATION FROM HOSPITALS, LHDS, NURSING HOMES, HOME CARE AGENCIES AND COMMUNITY HEALTH CENTERS TO AGGREGATE FOR SITUATIONAL AWARENESS ACROSS THE REGION. ALL INFORMATION SHARING OBJECTIVES WERE CONDUCTED USING INTEROPERABLE COMMUNICATION MODALITIES, EXCLUDING LANDLINES AND FAX MACHINES. THE EXERCISES WERE FOLLOWED BY WEBINARS WITH HOSPITAL EXECUTIVE STAFF, WITHIN THIRTY DAYS OF EACH EXERCISE. THE EXERCISE WAS CONDUCTED AT THE HEALTH CARE COALITION LEVEL AND PARTICIPANTS INCLUDED: FIFTY-SEVEN (57) LHDS, ONE HUNDRED THIRTY-NINE HOSPITALS (139), FIFTEEN (15) NURSING HOMES, FOUR (4) COMMUNITY HEALTH CENTERS, THIRTY-ONE (31) HOME HEALTHCARE AGENCIES AND TWENTY-FOUR (24) HOME CARE AGENCIES. 990, PART III, 4D. OTHER PROGRAM SERVICES BIOMEDICAL RESEARCH PUBLIC AFFAIRS GROUP CENTER FOR HEALTH WORKFORCE STUDIES DIVISION OF ADMINISTRATION AND INFORMATION SYSTEM TECHNOLOGY TRANSFER, INTERNALLY SPONSORED RESEARCH AND PUBLIC HEALTH PROGRAMS OFFICE OF PUBLIC HEALTH PROGRAMS AND RESEARCH CENTER FOR ENVIRONMENTAL HEALTH AND RESEARCH OTHER HIV/AIDS HEALTH AND SUPPORTIVE SERVICES, INCLUDING INTERNATIONAL OFFICE OF HEALTH SYSTEM MANAGEMENT OFFICE OF HEALTH INSURANCE PROGRAMS OFFICE OF LONG TERM CARE AGRICULTURE & MARKETS OFFICE OF QUALITY AND PATIENT SAFETY |
| FORM 990, PART VI, SECTION B, LINE 11B |
THE ANNUAL FORM 990 IS INITIATED BY THE CORPORATE CONTROLLER AND DEVELOPED IN CONJUNCTION WITH THE ASSISTANT DIRECTOR OF FINANCE AND OPERATIONS AND THE EXECUTIVE DIRECTOR. THE FINAL DRAFT IS REVIEWED BY THE THREE KEY PERSONNEL LISTED ABOVE. A COMPARATIVE ANALYSIS TO THE PRIOR YEAR'S FILING IS CONDUCTED AND THEN THE FINAL DRAFT IS PRESENTED TO HEALTH RESEARCH, INC'S INDEPENDENT AUDIT FIRM FOR VALIDATION. ONCE FINALIZED BY THE INDEPENDENT AUDIT FIRM, THE EXECUTIVE DIRECTOR PRESENTS AND REVIEWS THE FORM 990 FILING WITH THE CORPORATION'S SECRETARY/TREASURER AND IF REQUESTED, THE CORPORATION'S VICE PRESIDENT. A COPY OF THE 990 IS PROVIDED TO ALL DIRECTORS OF THE HRI BOARD FOR THEIR REVIEW PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C |
HRI CONFLICT OF INTEREST POLICIES ARE REVIEWED ANNUALLY AND IF APPROPRIATE, REVISED BY THE CORPORATION'S HOUSE COUNSEL AND EXECUTIVE DIRECTOR. THE MOST RECENT VERSION OF THE HRI EMPLOYEE CONFLICT OF INTEREST POLICY WAS UPDATED IN FEBRUARY 2017 AND PROVIDED TO EMPLOYEES IN APRIL 2017, VIA HRI'S ONLINE TRAINING SYSTEM. INDIVIDUALS ARE REQUIRED TO ATTEST TO READING THE POLICY; CONFIRMATION OF WHICH IS ELECTRONICALLY MAINTAINED BY CORPORATE HUMAN RESOURCE STAFF. IN ADDITION TO THE ANNUAL CERTIFICATION, ALL NEW EMPLOYEES ARE PROVIDED WITH A COPY OF EMPLOYEE CONFLICT OF INTEREST POLICY IN CONJUNCTION WITH NEW HIRE ORIENTATION, AND THE POLICY IS AVAILABLE ON THE HRI WEBSITE. ALL POTENTIAL CONFLICTS MUST BE DISCLOSED IN WRITING TO THE CORPORATE OFFICE FOR REVIEW AND CONSIDERATION BY MANAGEMENT. COMPLIANCE WITH THE PROVISIONS OF THE POLICY ARE MONITORED AND ENSURED THROUGH THE PRESENCE OF COMPLIMENTARY CONTROLS, SUCH AS THE HRI OUTSIDE EMPLOYMENT POLICY AND HONORARIA/TRAVEL EXPENSE REIMBURSEMENT POLICY. ANNUALLY, MEMBERS OF THE BOARD OF DIRECTORS, OFFICERS AND KEY EMPLOYEES ARE PROVIDED WITH A COPY OF THE CONFLICT OF INTEREST POLICY FOR BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES AND MUST CERTIFY THAT THEY HAVE READ AND UNDERSTAND THE POLICY, IN ADDITION TO DISCLOSING ALL CONFLICTS OF INTEREST. NEW HRI BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES ARE PROVIDED WITH A COPY OF THE POLICY AT THE TIME OF APPOINTMENT AND ARE REQUIRED TO DISCLOSE ANY CONFLICTS UPON RECEIPT. ATTESTATIONS AND DISCLOSURE FORMS ARE SENT TO THE HRI CORPORATE OFFICE AND THEN FORWARDED TO THE AUDIT COMMITTEE FOR REVIEW AND CONSIDERATION. RESTRICTIONS IMPOSED ARE CONDITIONED AND DETERMINED BY CIRCUMSTANCES AND RANGE FROM DENIAL OF THE REQUEST FOR AN EMPLOYEE TO RECUSAL FOR A DIRECTOR OF THE CORPORATION. |
| FORM 990, PART VI, SECTION B, LINE 15 |
SALARIES OF THE EXECUTIVE DIRECTOR AND ALL KEY EMPLOYEES ARE SET IN THE ANNUAL BUDGET. THIS IS REVIEWED AND APPROVED BY THE BOARD ANNUALLY. |
| FORM 990, PART VI, SECTION C, LINE 19 |
HEALTH RESEARCH, INC.'S GOVERNING DOCUMENTS: CONFLICT OF INTEREST POLICY, ETHICS POLICY, WHISTLEBLOWER POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. |
| FORM 990, PART X, INVESTMENTS - PUBLICLY TRADED SECURITIES: |
DESCRIPTION ENDING BOOK VALUE COST OR FMV US TREASURIES & SECURITIES $477,788,638 FMV TOTALS $477,788,638 |
| FORM 990, PART XII, LINE 2C: |
THERE HAVE BEEN NO CHANGES MADE TO THE OVERSIGHT AND SELECTION PROCESS DURING THE TAX PREP YEAR. |
Attach to Form 990 or 990-EZ.